NO940093L - Cholecystokinin-antagonister anvendelige ved behandling av panikk-angrep - Google Patents

Cholecystokinin-antagonister anvendelige ved behandling av panikk-angrep

Info

Publication number
NO940093L
NO940093L NO940093A NO940093A NO940093L NO 940093 L NO940093 L NO 940093L NO 940093 A NO940093 A NO 940093A NO 940093 A NO940093 A NO 940093A NO 940093 L NO940093 L NO 940093L
Authority
NO
Norway
Prior art keywords
treatment
panic attacks
antagonists useful
cholecystokinin antagonists
attacks
Prior art date
Application number
NO940093A
Other languages
English (en)
Other versions
NO940093D0 (no
Inventor
Geoffrey Neil Woodruff
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of NO940093D0 publication Critical patent/NO940093D0/no
Publication of NO940093L publication Critical patent/NO940093L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Unaturlige dipeptoider av a-substituerte Try-Phe- derivater er egnet som midler ved behandling av paniske for- styrrelser. Disse dipeptoider er CCKB-antagonister som har anvendelse ved forebygging av panikkanfall hos pasienter som har tilbøyelighet til å få slike anfall.
NO940093A 1991-07-12 1994-01-11 Cholecystokinin-antagonister anvendelige ved behandling av panikk-angrep NO940093L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72927191A 1991-07-12 1991-07-12
PCT/US1992/004839 WO1993000897A1 (en) 1991-07-12 1992-06-08 Cholecystokinin antagonists useful in the treatment of panic attacks

Publications (2)

Publication Number Publication Date
NO940093D0 NO940093D0 (no) 1994-01-11
NO940093L true NO940093L (no) 1994-03-08

Family

ID=24930307

Family Applications (1)

Application Number Title Priority Date Filing Date
NO940093A NO940093L (no) 1991-07-12 1994-01-11 Cholecystokinin-antagonister anvendelige ved behandling av panikk-angrep

Country Status (9)

Country Link
US (2) US5318981A (no)
EP (1) EP0594692A1 (no)
JP (1) JPH06509095A (no)
AU (1) AU665562B2 (no)
CA (1) CA2110986A1 (no)
CZ (1) CZ282536B6 (no)
IE (1) IE922268A1 (no)
NO (1) NO940093L (no)
WO (1) WO1993000897A1 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL163666A0 (en) 2002-02-22 2005-12-18 New River Pharmaceuticals Inc Active agent delivery systems and methods for protecting and administering active agents
CA2929858C (en) 2013-11-22 2022-03-29 CL BioSciences LLC Gastrin antagonists (eg yf476, netazepide) for treatment and prevention of osteoporosis
CN113533279B (zh) * 2021-07-15 2022-07-29 河北农业大学 一种利用荧光二肽纳米微球/核酸适配体检测恩诺沙星的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ234264A (en) * 1989-06-29 1993-05-26 Warner Lambert Co N-substituted cycloalkyl and polycycloalkyl alpha-substituted trp-phe- and phenethylamine derivatives, and pharmaceutical compositions
US5264419A (en) * 1990-08-31 1993-11-23 Warner-Lambert Company N-substituted cycloalkyl and polycycloalkyl α-substituted TRP derivatives
US5244915A (en) * 1990-08-31 1993-09-14 Warner-Lambert Company Amico acid derivatives cyclized at the c-terminal
JP3356431B2 (ja) * 1990-08-31 2002-12-16 ワーナー―ランバート・コンパニー Ｃｃｋアンタゴニストに対するプロ―ドラッグ

Also Published As

Publication number Publication date
JPH06509095A (ja) 1994-10-13
AU2302292A (en) 1993-02-11
IE922268A1 (en) 1993-01-13
US5318981A (en) 1994-06-07
EP0594692A1 (en) 1994-05-04
CZ291093A3 (en) 1994-04-13
US5451602A (en) 1995-09-19
CA2110986A1 (en) 1993-01-21
NO940093D0 (no) 1994-01-11
AU665562B2 (en) 1996-01-11
WO1993000897A1 (en) 1993-01-21
CZ282536B6 (cs) 1997-08-13

Similar Documents

Publication Publication Date Title
NO20092860L (no) 2, 6 dioksopiperidin samt farmasoytiske preparater som inneholder disse
BR9907995A (pt) Métodos imunológicos para modular miostatina em sujeitos vertebrados
DE122009000012I1 (de) Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen.
DE69616480D1 (de) Piperidinderivate als neurokininantagonisten
GB9406857D0 (en) Improvements in or relating to organic compounds
DE69200685D1 (de) Benzocyclobutyl- oder Indanyl-Alkyl-Amino-Alkyl substituierte 3-Benzazepin-2-ones, verwendbar in der Behandlung von kardiovaskularen Krankheiten.
NO961326D0 (no) Inhibitorer av
BG102425A (en) (methylsulphonyl)phenyl-2-(5h)-furanons as cyclooxygenase-2-inhibitors
DE69805973T2 (de) Behandlung von herzrythmusstörungen durch hemmung einer multifunktionalen calcium/calmodulin-abhängigen protein kinase
KR960701051A (ko) 이미다조피리딘 및 이를 위장 질환의 치료에 사용하는 방법(imidazopyridines and their use in treating castrointestinal diseases)
DE69431601T2 (de) Neue verwendung von dexmedetomidin
ATE201597T1 (de) Verabreichung von riluzol zur behandlung von neuro-aids
PT758241E (pt) Utilizacao de certos derivados de acido metanobisfosfonico para impedir o desprendimento de proteses e a migracao de proteses
AU6452194A (en) Pharmaceutical agents for treatment of emesis
NO990701L (no) Behandling av vanlig forkj°lelse eller allergisk rhinitt
DK1032556T3 (da) Farmaceutisk aktive forbindelser og anvendelsesfremgangsmåder
GB2274777B (en) Synergistic combination of compounds having an antagonist effect on nk1 and on nk2 receptors
DK1035859T3 (da) Anvendelse af phospholipidkomplekser fra ekstrakter af Vitis vinifera som anti-atherosklerotiske midler
FI974640A (fi) Migreenin hoitoon tarkoitetut 1,6-disubstituoidut isokromaanit
NO940093L (no) Cholecystokinin-antagonister anvendelige ved behandling av panikk-angrep
DE69735417D1 (de) 2,5-dihydroxybenzylsulfonderivate zur behandlung von sexuellen störungen
NO923393L (no) Fremgangsmaate for inhibering av korrosjon i broenner som syrebehandle
ES2150418T3 (es) Composiciones farmaceuticas que comprenden calcitonina.
ATE294802T1 (de) 3-alkylimidazopyridine
RU93058537A (ru) Применение атипамезола для лечения мужской сексуальной импотенции